Light-Activated Drug and Gene Delivery System ID: 2012-030
A novel technique utilizing near-infrared light for targeted delivery of drugs and genes directly into cell cytosol.
Photo by sudok1 - stock.adobe.com
Technology Overview
This technology involves a light-activated method using perfluorocarbon nano-sized vesicles associated with liposomes to deliver drugs or genes into cells. Upon exposure to near-infrared light, these vesicles heat and transform from liquid to gas, causing the liposome to rupture and release its therapeutic contents into the cell's cytosol. This innovative approach aims to enhance the efficacy of therapeutic treatments by ensuring targeted delivery.
Key Advantages
- Targeted delivery of therapeutics directly into cell cytosol
- Non-invasive method using near-infrared light
- Utilization of non-toxic materials ensuring safety
- Improved therapeutic outcomes for treatments such as chemotherapy and gene therapy
- Unique method of using light to trigger endosomal escape
Problems Addressed
- Inefficient delivery of drugs and genes to the desired cellular location
- High toxicity and side effects of traditional delivery methods
- Limited capability in targeting specific cells or tissues
- Obstacles in endosomal escape, hindering therapeutic efficacy
Market Applications
- Chemotherapy treatments
- Gene therapy applications
- Biomedical research
- Development of non-invasive therapeutic delivery systems
- Pharmaceutical companies interested in advanced drug delivery technologies
Additional Information
Technology ID: 2012-030
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 30 June, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report